Previously reported in vitro data suggest that CCND1 overexpression is dependent on the presence of oestrogen and oestrogen receptors, and that anti-oestrogens inhibit cyclin D1 expression in breast cancer cells (Sutherland et al, 1997). Here, CCND1 is linked to breast carcinoma.